

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.43581075 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.43581075 |
| 3 | aromatic amino acid family catabolic process (GO:0009074) | 4.19201909 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.08159671 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.08159671 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05829634 |
| 7 | complement activation, alternative pathway (GO:0006957) | 3.98454163 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.93314679 |
| 9 | protein carboxylation (GO:0018214) | 3.93314679 |
| 10 | urea metabolic process (GO:0019627) | 3.93311481 |
| 11 | urea cycle (GO:0000050) | 3.93311481 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 3.92412538 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 3.92412538 |
| 14 | tryptophan catabolic process (GO:0006569) | 3.92412538 |
| 15 | tryptophan metabolic process (GO:0006568) | 3.77780873 |
| 16 | bile acid biosynthetic process (GO:0006699) | 3.70887908 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 3.69639399 |
| 18 | bile acid and bile salt transport (GO:0015721) | 3.66314294 |
| 19 | regulation of protein activation cascade (GO:2000257) | 3.64540154 |
| 20 | kynurenine metabolic process (GO:0070189) | 3.61667504 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 3.56493088 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 3.56224450 |
| 23 | regulation of complement activation (GO:0030449) | 3.47500818 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 3.41819226 |
| 25 | phospholipid efflux (GO:0033700) | 3.41690697 |
| 26 | regulation of mononuclear cell migration (GO:0071675) | 3.41535743 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 3.39557526 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35886898 |
| 29 | glyoxylate metabolic process (GO:0046487) | 3.35877021 |
| 30 | homocysteine metabolic process (GO:0050667) | 3.35635253 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 3.35577439 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 3.32585156 |
| 33 | regulation of vitamin metabolic process (GO:0030656) | 3.29272388 |
| 34 | regulation of fibrinolysis (GO:0051917) | 3.27704587 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.24622646 |
| 36 | cysteine metabolic process (GO:0006534) | 3.24223352 |
| 37 | cellular glucuronidation (GO:0052695) | 3.23496824 |
| 38 | reverse cholesterol transport (GO:0043691) | 3.22707506 |
| 39 | bile acid metabolic process (GO:0008206) | 3.22601963 |
| 40 | negative regulation of interleukin-12 production (GO:0032695) | 3.20681449 |
| 41 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.20580873 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.19431516 |
| 43 | skeletal muscle adaptation (GO:0043501) | 3.18881410 |
| 44 | phospholipid homeostasis (GO:0055091) | 3.17983647 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17693391 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.17693391 |
| 47 | striated muscle atrophy (GO:0014891) | 3.13933006 |
| 48 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.12780189 |
| 49 | eosinophil chemotaxis (GO:0048245) | 3.11192770 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 3.10290639 |
| 51 | acute-phase response (GO:0006953) | 3.09978742 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 3.09739412 |
| 53 | macromolecular complex remodeling (GO:0034367) | 3.09739412 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 3.09739412 |
| 55 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08254661 |
| 56 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08254661 |
| 57 | modulation by symbiont of host immune response (GO:0052553) | 3.08254661 |
| 58 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08254661 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 3.08254661 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08254661 |
| 61 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05939072 |
| 62 | cholesterol efflux (GO:0033344) | 3.05516857 |
| 63 | uronic acid metabolic process (GO:0006063) | 3.05393763 |
| 64 | glucuronate metabolic process (GO:0019585) | 3.05393763 |
| 65 | macroautophagy (GO:0016236) | 2.96269642 |
| 66 | fibrinolysis (GO:0042730) | 2.96023270 |
| 67 | tyrosine metabolic process (GO:0006570) | 2.93922335 |
| 68 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.93578792 |
| 69 | cellular response to ethanol (GO:0071361) | 2.90471813 |
| 70 | acylglycerol homeostasis (GO:0055090) | 2.89296746 |
| 71 | triglyceride homeostasis (GO:0070328) | 2.89296746 |
| 72 | positive regulation of interferon-alpha production (GO:0032727) | 2.88782527 |
| 73 | aromatic amino acid family metabolic process (GO:0009072) | 2.87996684 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 2.85738611 |
| 75 | lysine catabolic process (GO:0006554) | 2.81749999 |
| 76 | lysine metabolic process (GO:0006553) | 2.81749999 |
| 77 | aldehyde catabolic process (GO:0046185) | 2.81477179 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 2.80278998 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 2.78567672 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 2.77500515 |
| 81 | complement activation (GO:0006956) | 2.76734790 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.76517119 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.76517119 |
| 84 | indolalkylamine metabolic process (GO:0006586) | 2.75852383 |
| 85 | neutrophil activation involved in immune response (GO:0002283) | 2.74930376 |
| 86 | regulation of interferon-alpha production (GO:0032647) | 2.73671500 |
| 87 | eosinophil migration (GO:0072677) | 2.72274680 |
| 88 | regulation of cholesterol storage (GO:0010885) | 2.71002935 |
| 89 | protein activation cascade (GO:0072376) | 2.70606318 |
| 90 | complement activation, classical pathway (GO:0006958) | 2.69846940 |
| 91 | low-density lipoprotein particle clearance (GO:0034383) | 2.69628745 |
| 92 | amine catabolic process (GO:0009310) | 2.68153923 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 2.68153923 |
| 94 | epoxygenase P450 pathway (GO:0019373) | 2.66534008 |
| 95 | cholesterol homeostasis (GO:0042632) | 2.66020076 |
| 96 | lipoprotein metabolic process (GO:0042157) | 2.65703266 |
| 97 | T-helper 1 type immune response (GO:0042088) | 2.65475605 |
| 98 | sterol homeostasis (GO:0055092) | 2.65136545 |
| 99 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.63962617 |
| 100 | protein-lipid complex assembly (GO:0065005) | 2.63867979 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.63818880 |
| 102 | glycosphingolipid catabolic process (GO:0046479) | 2.63478433 |
| 103 | benzene-containing compound metabolic process (GO:0042537) | 2.62973715 |
| 104 | regulation of skeletal muscle contraction (GO:0014819) | 2.62577287 |
| 105 | flavonoid metabolic process (GO:0009812) | 2.61569926 |
| 106 | opsonization (GO:0008228) | 2.60727516 |
| 107 | arginine metabolic process (GO:0006525) | 2.59560858 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 2.58857445 |
| 109 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.57995655 |
| 110 | positive regulation of hemostasis (GO:1900048) | 2.57603611 |
| 111 | positive regulation of blood coagulation (GO:0030194) | 2.57603611 |
| 112 | ethanol oxidation (GO:0006069) | 2.57510017 |
| 113 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56910280 |
| 114 | muscle filament sliding (GO:0030049) | 2.56494307 |
| 115 | actin-myosin filament sliding (GO:0033275) | 2.56494307 |
| 116 | negative regulation of lipid storage (GO:0010888) | 2.56071729 |
| 117 | skeletal muscle contraction (GO:0003009) | 2.55197290 |
| 118 | drug transmembrane transport (GO:0006855) | 2.54442164 |
| 119 | glycolipid catabolic process (GO:0019377) | 2.54154619 |
| 120 | alpha-amino acid catabolic process (GO:1901606) | 2.53739150 |
| 121 | NAD biosynthetic process (GO:0009435) | 2.53379305 |
| 122 | alkaloid metabolic process (GO:0009820) | 2.52922723 |
| 123 | positive regulation of coagulation (GO:0050820) | 2.52514115 |
| 124 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.51495779 |
| 125 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.48877963 |
| 126 | regulation of chronic inflammatory response (GO:0002676) | 2.47591885 |
| 127 | positive regulation of fatty acid oxidation (GO:0046321) | 2.46510406 |
| 128 | regulation of macrophage chemotaxis (GO:0010758) | 2.44656970 |
| 129 | positive regulation of heat generation (GO:0031652) | 2.44636173 |
| 130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.44200732 |
| 131 | diol metabolic process (GO:0034311) | 2.43616644 |
| 132 | sphingosine metabolic process (GO:0006670) | 2.42722886 |
| 133 | ceramide catabolic process (GO:0046514) | 2.42601840 |
| 134 | muscle atrophy (GO:0014889) | 2.42600973 |
| 135 | exogenous drug catabolic process (GO:0042738) | 2.41408877 |
| 136 | sphingoid metabolic process (GO:0046519) | 2.40575939 |
| 137 | angiotensin maturation (GO:0002003) | 2.39878347 |
| 138 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.39411783 |
| 139 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.39280990 |
| 140 | drug catabolic process (GO:0042737) | 2.38480289 |
| 141 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.38222569 |
| 142 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.36170375 |
| 143 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.31681169 |
| 144 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.30048556 |
| 145 | actin-mediated cell contraction (GO:0070252) | 2.29549123 |
| 146 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.29064372 |
| 147 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.28381331 |
| 148 | nitric oxide biosynthetic process (GO:0006809) | 2.28317216 |
| 149 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.28252551 |
| 150 | response to type I interferon (GO:0034340) | 2.27662785 |
| 151 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.27123878 |
| 152 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.27016883 |
| 153 | virion attachment to host cell (GO:0019062) | 2.26358483 |
| 154 | adhesion of symbiont to host cell (GO:0044650) | 2.26358483 |
| 155 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.25711368 |
| 156 | cellular response to exogenous dsRNA (GO:0071360) | 2.24710917 |
| 157 | fatty acid transmembrane transport (GO:1902001) | 2.23842019 |
| 158 | intestinal epithelial cell development (GO:0060576) | 2.22633252 |
| 159 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.22388141 |
| 160 | regulation of sequestering of triglyceride (GO:0010889) | 2.20444984 |
| 161 | type I interferon signaling pathway (GO:0060337) | 2.19370222 |
| 162 | cellular response to type I interferon (GO:0071357) | 2.19370222 |
| 163 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.19214239 |
| 164 | detection of molecule of bacterial origin (GO:0032490) | 2.18698918 |
| 165 | regulation of T cell tolerance induction (GO:0002664) | 2.18682121 |
| 166 | regulation of cellular extravasation (GO:0002691) | 2.18011881 |
| 167 | transcytosis (GO:0045056) | 2.16465834 |
| 168 | response to muscle activity (GO:0014850) | 2.16198902 |
| 169 | membrane lipid catabolic process (GO:0046466) | 2.14924201 |
| 170 | iron ion import (GO:0097286) | 2.13181506 |
| 171 | omega-hydroxylase P450 pathway (GO:0097267) | 2.13049461 |
| 172 | regulation of fever generation (GO:0031620) | 2.12168092 |
| 173 | intestinal absorption (GO:0050892) | 2.11770483 |
| 174 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.11001530 |
| 175 | protein targeting to vacuole (GO:0006623) | 2.10775921 |
| 176 | protein targeting to lysosome (GO:0006622) | 2.10775921 |
| 177 | establishment of protein localization to vacuole (GO:0072666) | 2.10775921 |
| 178 | positive regulation of antigen processing and presentation (GO:0002579) | 2.08811258 |
| 179 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.08579886 |
| 180 | regulation of lipid storage (GO:0010883) | 2.07966745 |
| 181 | germinal center formation (GO:0002467) | 2.04773597 |
| 182 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.04181147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.41305787 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65926276 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.36367267 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.17841676 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.06482903 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97867182 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32683815 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.27274677 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.89703590 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72793751 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.72688935 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.72076985 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65436497 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64722833 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55166031 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.50227944 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.44738044 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38895096 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25532395 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19587986 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17837581 |
| 22 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17321878 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12008963 |
| 24 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.02205971 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91101609 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.84328917 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81755971 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.80024913 |
| 29 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.75921538 |
| 30 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70046683 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69808275 |
| 32 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65990947 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58735171 |
| 34 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.56159395 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46504878 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45151495 |
| 37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43325671 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40449343 |
| 39 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40449343 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40246465 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38857456 |
| 42 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.35783125 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35758343 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34507246 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34332375 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31923043 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31849324 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31551449 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.30734522 |
| 50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.30434976 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.29940111 |
| 52 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28883355 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26820923 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26639781 |
| 55 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26551758 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25139561 |
| 57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24950217 |
| 58 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23355878 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22085094 |
| 60 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21625802 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21353710 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20661168 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20016324 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19820448 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19443946 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17769080 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17167251 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15978751 |
| 69 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15871870 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15717332 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15614292 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15393189 |
| 73 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15057375 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14845581 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14834143 |
| 76 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.14801656 |
| 77 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14333511 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14195400 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.14172777 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12572045 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12494506 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10298468 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08905557 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08516166 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07069181 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06835632 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06622439 |
| 88 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05955486 |
| 89 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04785716 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02451488 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01682892 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01439852 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01422617 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01206452 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01136278 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01122278 |
| 97 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00718110 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97276513 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96861413 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96830577 |
| 101 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95644660 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94665600 |
| 103 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93873128 |
| 104 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92717281 |
| 105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91869653 |
| 106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90477722 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90310370 |
| 108 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90272059 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.90098661 |
| 110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89628995 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89225269 |
| 112 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88439631 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88095144 |
| 114 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.87766184 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86959437 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86457044 |
| 117 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86127343 |
| 118 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.85616011 |
| 119 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85426124 |
| 120 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84093989 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82965825 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82615256 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82330830 |
| 124 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80351776 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79610866 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79610866 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77683945 |
| 128 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77421155 |
| 129 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.76965128 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75687902 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75015424 |
| 132 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74198799 |
| 133 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.72213735 |
| 134 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70546342 |
| 135 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69694602 |
| 136 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69450345 |
| 137 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69406618 |
| 138 | GATA3_26560356_Chip-Seq_TH2_Human | 0.68855586 |
| 139 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67932121 |
| 140 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.66443312 |
| 141 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.66434345 |
| 142 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66395976 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65974560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.86195918 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.84442689 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.87365663 |
| 4 | MP0005365_abnormal_bile_salt | 3.58791733 |
| 5 | MP0003646_muscle_fatigue | 3.40978859 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.00681584 |
| 7 | MP0003252_abnormal_bile_duct | 2.89158176 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.61249788 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 2.46344641 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.37105081 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.36221832 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.28308881 |
| 13 | MP0009840_abnormal_foam_cell | 2.27888462 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.26485353 |
| 15 | MP0003724_increased_susceptibility_to | 2.22836284 |
| 16 | MP0003436_decreased_susceptibility_to | 2.19401061 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.16953091 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.13800390 |
| 19 | MP0003195_calcinosis | 2.08380565 |
| 20 | MP0009785_altered_susceptibility_to | 2.08150986 |
| 21 | MP0002254_reproductive_system_inflammat | 2.02361983 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.01939064 |
| 23 | MP0005083_abnormal_biliary_tract | 1.95211053 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.93551518 |
| 25 | MP0006082_CNS_inflammation | 1.90085135 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.83049216 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.82831517 |
| 28 | MP0002332_abnormal_exercise_endurance | 1.78457100 |
| 29 | MP0002419_abnormal_innate_immunity | 1.76237458 |
| 30 | MP0001790_abnormal_immune_system | 1.70408759 |
| 31 | MP0005387_immune_system_phenotype | 1.70408759 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.69345081 |
| 33 | MP0005332_abnormal_amino_acid | 1.68896060 |
| 34 | MP0009764_decreased_sensitivity_to | 1.68051225 |
| 35 | MP0004019_abnormal_vitamin_homeostasis | 1.66090015 |
| 36 | MP0005025_abnormal_response_to | 1.62816995 |
| 37 | MP0000609_abnormal_liver_physiology | 1.62328176 |
| 38 | MP0000749_muscle_degeneration | 1.61005304 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.60850218 |
| 40 | MP0000685_abnormal_immune_system | 1.58261335 |
| 41 | MP0003303_peritoneal_inflammation | 1.53472109 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.52256061 |
| 43 | MP0004043_abnormal_pH_regulation | 1.51456245 |
| 44 | MP0004947_skin_inflammation | 1.49174577 |
| 45 | MP0008469_abnormal_protein_level | 1.49154419 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.47926397 |
| 47 | MP0002118_abnormal_lipid_homeostasis | 1.41079302 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.38701253 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.38330909 |
| 50 | MP0001800_abnormal_humoral_immune | 1.34972177 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.33471951 |
| 52 | MP0004036_abnormal_muscle_relaxation | 1.33124929 |
| 53 | MP0005671_abnormal_response_to | 1.30199611 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.30195903 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.28992296 |
| 56 | MP0000604_amyloidosis | 1.26488659 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.26096210 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.25270196 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24756239 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.24456997 |
| 61 | MP0002723_abnormal_immune_serum | 1.24155991 |
| 62 | MP0006054_spinal_hemorrhage | 1.23968914 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.22695841 |
| 64 | MP0001853_heart_inflammation | 1.19328261 |
| 65 | MP0004084_abnormal_cardiac_muscle | 1.16798595 |
| 66 | MP0003186_abnormal_redox_activity | 1.16669446 |
| 67 | MP0003075_altered_response_to | 1.16343715 |
| 68 | MP0009763_increased_sensitivity_to | 1.14562069 |
| 69 | MP0003690_abnormal_glial_cell | 1.13362543 |
| 70 | MP0000383_abnormal_hair_follicle | 1.12994833 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.10397139 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.09611010 |
| 73 | MP0003868_abnormal_feces_composition | 1.08047044 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.08002831 |
| 75 | MP0005310_abnormal_salivary_gland | 1.06311647 |
| 76 | MP0005620_abnormal_muscle_contractility | 1.06131531 |
| 77 | MP0004510_myositis | 1.05563793 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.03568660 |
| 79 | MP0004484_altered_response_of | 1.03105694 |
| 80 | MP0002006_tumorigenesis | 1.00410196 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.99344616 |
| 82 | MP0001819_abnormal_immune_cell | 0.98846769 |
| 83 | MP0005451_abnormal_body_composition | 0.97093979 |
| 84 | MP0005166_decreased_susceptibility_to | 0.96902249 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.96512805 |
| 86 | MP0004883_abnormal_blood_vessel | 0.96354476 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.95092658 |
| 88 | MP0000427_abnormal_hair_cycle | 0.94586462 |
| 89 | MP0003828_pulmonary_edema | 0.94326346 |
| 90 | MP0001542_abnormal_bone_strength | 0.93545220 |
| 91 | MP0005330_cardiomyopathy | 0.93438777 |
| 92 | MP0000598_abnormal_liver_morphology | 0.92673938 |
| 93 | MP0005164_abnormal_response_to | 0.91117734 |
| 94 | MP0000747_muscle_weakness | 0.90307542 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.89522563 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.89292171 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.88878957 |
| 98 | MP0002009_preneoplasia | 0.88188098 |
| 99 | MP0000343_altered_response_to | 0.88108663 |
| 100 | MP0002106_abnormal_muscle_physiology | 0.87750947 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.87176616 |
| 102 | MP0001764_abnormal_homeostasis | 0.86699906 |
| 103 | MP0004233_abnormal_muscle_weight | 0.86509934 |
| 104 | MP0002168_other_aberrant_phenotype | 0.86379859 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.86188714 |
| 106 | MP0002972_abnormal_cardiac_muscle | 0.85700141 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.85090708 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.84904012 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.84342759 |
| 110 | MP0001663_abnormal_digestive_system | 0.84062665 |
| 111 | MP0001881_abnormal_mammary_gland | 0.83964411 |
| 112 | MP0005266_abnormal_metabolism | 0.82944869 |
| 113 | MP0000230_abnormal_systemic_arterial | 0.82046141 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.81037993 |
| 115 | MP0005408_hypopigmentation | 0.81036247 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.80105680 |
| 117 | MP0001958_emphysema | 0.79304482 |
| 118 | MP0004130_abnormal_muscle_cell | 0.79292412 |
| 119 | MP0000371_diluted_coat_color | 0.78083229 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.77889679 |
| 121 | MP0002405_respiratory_system_inflammati | 0.77800216 |
| 122 | MP0002796_impaired_skin_barrier | 0.76906109 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.76274253 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.75553792 |
| 125 | MP0005275_abnormal_skin_tensile | 0.75471043 |
| 126 | MP0001873_stomach_inflammation | 0.75443544 |
| 127 | MP0000249_abnormal_blood_vessel | 0.74347343 |
| 128 | MP0002933_joint_inflammation | 0.73877866 |
| 129 | MP0003045_fibrosis | 0.73674320 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.71610701 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.71272250 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.70431140 |
| 133 | MP0003448_altered_tumor_morphology | 0.69923562 |
| 134 | MP0009697_abnormal_copulation | 0.69559443 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.66486996 |
| 136 | MP0001756_abnormal_urination | 0.65776060 |
| 137 | MP0001216_abnormal_epidermal_layer | 0.64034952 |
| 138 | MP0002971_abnormal_brown_adipose | 0.64034056 |
| 139 | MP0002060_abnormal_skin_morphology | 0.63970171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.07594046 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.07594046 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.07594046 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.79528692 |
| 5 | Complement deficiency (HP:0004431) | 4.76464855 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.67996058 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.57895157 |
| 8 | Xanthomatosis (HP:0000991) | 4.54516872 |
| 9 | Nemaline bodies (HP:0003798) | 4.51990256 |
| 10 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.48950333 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43670023 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.42401652 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.42263643 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.40555299 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.25971145 |
| 16 | Joint hemorrhage (HP:0005261) | 3.96314526 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.95697277 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.77918387 |
| 19 | Abnormality of complement system (HP:0005339) | 3.66460645 |
| 20 | Myocardial infarction (HP:0001658) | 3.66153658 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58510448 |
| 22 | Hypobetalipoproteinemia (HP:0003563) | 3.58445607 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 3.54955873 |
| 24 | Glomerulonephritis (HP:0000099) | 3.48391178 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 3.42911745 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.41189922 |
| 27 | Epidermoid cyst (HP:0200040) | 3.25813094 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 3.25373544 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.24950740 |
| 30 | Fat malabsorption (HP:0002630) | 3.16867198 |
| 31 | Recurrent abscess formation (HP:0002722) | 3.15414821 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 3.07671532 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.01432713 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.98558709 |
| 35 | Hypolipoproteinemia (HP:0010981) | 2.97181496 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 2.94072629 |
| 37 | Esophageal varix (HP:0002040) | 2.88875531 |
| 38 | Gingival bleeding (HP:0000225) | 2.88158137 |
| 39 | Decreased circulating renin level (HP:0003351) | 2.88000224 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.86272907 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.80825817 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.79583674 |
| 43 | Optic neuritis (HP:0100653) | 2.79583674 |
| 44 | Hyperammonemia (HP:0001987) | 2.77142682 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.73432750 |
| 46 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.71210635 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.68992984 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.68992984 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.68992984 |
| 50 | Exercise-induced myalgia (HP:0003738) | 2.68306579 |
| 51 | Nephritis (HP:0000123) | 2.66843461 |
| 52 | Axonal loss (HP:0003447) | 2.65585490 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.64636416 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60088932 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.56451442 |
| 56 | Steatorrhea (HP:0002570) | 2.50638869 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 2.48347256 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.47923409 |
| 59 | Amyloidosis (HP:0011034) | 2.47158142 |
| 60 | Malnutrition (HP:0004395) | 2.44115000 |
| 61 | Frequent falls (HP:0002359) | 2.41296699 |
| 62 | Abnormality of methionine metabolism (HP:0010901) | 2.41107836 |
| 63 | Recurrent skin infections (HP:0001581) | 2.38247066 |
| 64 | Thick nail (HP:0001805) | 2.37864644 |
| 65 | Mitral stenosis (HP:0001718) | 2.33113015 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.32978304 |
| 67 | Hyporeflexia of lower limbs (HP:0002600) | 2.32597844 |
| 68 | Ketosis (HP:0001946) | 2.30046355 |
| 69 | Stomatitis (HP:0010280) | 2.28771653 |
| 70 | Vascular calcification (HP:0004934) | 2.28235713 |
| 71 | Abnormality of proline metabolism (HP:0010907) | 2.26396936 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.26396936 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.24342260 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.22693861 |
| 75 | Ulnar deviation of the wrist (HP:0003049) | 2.21942020 |
| 76 | Chronic diarrhea (HP:0002028) | 2.21750853 |
| 77 | Pustule (HP:0200039) | 2.21662279 |
| 78 | Exercise-induced muscle cramps (HP:0003710) | 2.21514196 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20424222 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.18705733 |
| 81 | Hyperkalemia (HP:0002153) | 2.17645617 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.17388934 |
| 83 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14991920 |
| 84 | Gastrointestinal infarctions (HP:0005244) | 2.13798069 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.13419166 |
| 86 | Bundle branch block (HP:0011710) | 2.13314666 |
| 87 | Ovoid vertebral bodies (HP:0003300) | 2.13072965 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.12111483 |
| 89 | Thrombophlebitis (HP:0004418) | 2.12087237 |
| 90 | Disinhibition (HP:0000734) | 2.11922340 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.11331679 |
| 92 | Gingivitis (HP:0000230) | 2.09597896 |
| 93 | Fair hair (HP:0002286) | 2.08842257 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.08411363 |
| 95 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06779079 |
| 96 | Pulmonary embolism (HP:0002204) | 2.05687903 |
| 97 | Bone cyst (HP:0012062) | 2.04535808 |
| 98 | Spontaneous abortion (HP:0005268) | 2.04306499 |
| 99 | Distal arthrogryposis (HP:0005684) | 2.04095823 |
| 100 | Periodontitis (HP:0000704) | 2.02909306 |
| 101 | Neck muscle weakness (HP:0000467) | 2.02424034 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02404879 |
| 103 | Hemoptysis (HP:0002105) | 2.01532308 |
| 104 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01329536 |
| 105 | Nausea (HP:0002018) | 2.00924768 |
| 106 | Rhabdomyolysis (HP:0003201) | 2.00800326 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.99493339 |
| 108 | Dysostosis multiplex (HP:0000943) | 1.99474378 |
| 109 | Hyperbilirubinemia (HP:0002904) | 1.99259437 |
| 110 | Myositis (HP:0100614) | 1.99117804 |
| 111 | Hyperglycinemia (HP:0002154) | 1.99025723 |
| 112 | Hyperglycinuria (HP:0003108) | 1.98228944 |
| 113 | Cone-rod dystrophy (HP:0000548) | 1.96743095 |
| 114 | Skin nodule (HP:0200036) | 1.96278604 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 1.95622910 |
| 116 | Hematochezia (HP:0002573) | 1.94777719 |
| 117 | Muscle fiber splitting (HP:0003555) | 1.94693783 |
| 118 | Vasculitis (HP:0002633) | 1.94373770 |
| 119 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94100418 |
| 120 | Abnormality of glycine metabolism (HP:0010895) | 1.94100418 |
| 121 | Urticaria (HP:0001025) | 1.93724811 |
| 122 | Hypokalemia (HP:0002900) | 1.93530496 |
| 123 | Menorrhagia (HP:0000132) | 1.93418371 |
| 124 | Myoglobinuria (HP:0002913) | 1.92379448 |
| 125 | Pancreatitis (HP:0001733) | 1.92364739 |
| 126 | Peritonitis (HP:0002586) | 1.91204691 |
| 127 | T lymphocytopenia (HP:0005403) | 1.90870247 |
| 128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.90552660 |
| 129 | Increased serum ferritin (HP:0003281) | 1.90220960 |
| 130 | Loss of speech (HP:0002371) | 1.88888701 |
| 131 | Tetraparesis (HP:0002273) | 1.88376684 |
| 132 | Abnormality of potassium homeostasis (HP:0011042) | 1.87917799 |
| 133 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87751196 |
| 134 | Osteolytic defects of the hand bones (HP:0009699) | 1.87751196 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87347182 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.87347182 |
| 137 | Increased cerebral lipofuscin (HP:0011813) | 1.87163905 |
| 138 | Abnormal cartilage morphology (HP:0002763) | 1.86786248 |
| 139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.86179809 |
| 140 | Myopathic facies (HP:0002058) | 1.85473236 |
| 141 | Recurrent fungal infections (HP:0002841) | 1.84316981 |
| 142 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83994472 |
| 143 | Epistaxis (HP:0000421) | 1.83332495 |
| 144 | Generalized hypopigmentation of hair (HP:0011358) | 1.83059683 |
| 145 | Metabolic alkalosis (HP:0200114) | 1.82638649 |
| 146 | Anorexia (HP:0002039) | 1.82030099 |
| 147 | Interstitial pulmonary disease (HP:0006530) | 1.81649501 |
| 148 | Orchitis (HP:0100796) | 1.81366926 |
| 149 | J-shaped sella turcica (HP:0002680) | 1.80967319 |
| 150 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79965309 |
| 151 | Clumsiness (HP:0002312) | 1.78588425 |
| 152 | Abnormality of the pericardium (HP:0001697) | 1.78430441 |
| 153 | Joint swelling (HP:0001386) | 1.78211499 |
| 154 | Syncope (HP:0001279) | 1.78072858 |
| 155 | Acanthocytosis (HP:0001927) | 1.75532140 |
| 156 | Facial diplegia (HP:0001349) | 1.75523241 |
| 157 | Metaphyseal irregularity (HP:0003025) | 1.75498499 |
| 158 | Protuberant abdomen (HP:0001538) | 1.75406580 |
| 159 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74900659 |
| 160 | Keratoconjunctivitis sicca (HP:0001097) | 1.72323989 |
| 161 | Abnormality of alanine metabolism (HP:0010916) | 1.71254366 |
| 162 | Hyperalaninemia (HP:0003348) | 1.71254366 |
| 163 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.71254366 |
| 164 | Congenital, generalized hypertrichosis (HP:0004540) | 1.70412520 |
| 165 | Abnormality of renin-angiotensin system (HP:0000847) | 1.68482142 |
| 166 | Rimmed vacuoles (HP:0003805) | 1.67996884 |
| 167 | Large for gestational age (HP:0001520) | 1.67915386 |
| 168 | Generalized aminoaciduria (HP:0002909) | 1.67043679 |
| 169 | Keratoconjunctivitis (HP:0001096) | 1.65209718 |
| 170 | Abnormality of the renal cortex (HP:0011035) | 1.64666234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.56609631 |
| 2 | OBSCN | 4.31518673 |
| 3 | ACVR1B | 4.07584745 |
| 4 | MAP3K14 | 3.82458419 |
| 5 | TYK2 | 2.82564875 |
| 6 | ADRBK2 | 2.82448527 |
| 7 | FGFR4 | 2.73287320 |
| 8 | TBK1 | 2.49264732 |
| 9 | ERN1 | 2.24515938 |
| 10 | JAK1 | 2.15093278 |
| 11 | IKBKE | 2.10407717 |
| 12 | EPHB1 | 2.05097318 |
| 13 | SIK1 | 1.97432414 |
| 14 | FRK | 1.96625359 |
| 15 | IRAK3 | 1.93652525 |
| 16 | CAMKK2 | 1.92684741 |
| 17 | MST1R | 1.92508150 |
| 18 | MAPKAPK3 | 1.88813487 |
| 19 | CSF1R | 1.87668858 |
| 20 | IRAK4 | 1.83963257 |
| 21 | TGFBR2 | 1.83470210 |
| 22 | EPHA3 | 1.82896487 |
| 23 | JAK3 | 1.81107113 |
| 24 | RIPK4 | 1.74050211 |
| 25 | PBK | 1.61370218 |
| 26 | RIPK1 | 1.59780405 |
| 27 | IKBKB | 1.55610314 |
| 28 | DDR2 | 1.50111389 |
| 29 | MUSK | 1.46486979 |
| 30 | PIK3CA | 1.46163007 |
| 31 | NEK9 | 1.44279388 |
| 32 | EPHB2 | 1.43463506 |
| 33 | PINK1 | 1.43327601 |
| 34 | KIT | 1.42770340 |
| 35 | BLK | 1.40685725 |
| 36 | MAP3K13 | 1.40204789 |
| 37 | CSK | 1.36599893 |
| 38 | PIK3CG | 1.34280925 |
| 39 | FGFR3 | 1.32379206 |
| 40 | GRK1 | 1.32205670 |
| 41 | STK3 | 1.31762562 |
| 42 | INSRR | 1.31197471 |
| 43 | PTK6 | 1.27840009 |
| 44 | LATS1 | 1.24033450 |
| 45 | STK38L | 1.22353747 |
| 46 | PHKG2 | 1.21847365 |
| 47 | PHKG1 | 1.21847365 |
| 48 | MYLK | 1.21828788 |
| 49 | JAK2 | 1.19513925 |
| 50 | BCKDK | 1.18728387 |
| 51 | TXK | 1.16904563 |
| 52 | TLK1 | 1.13325107 |
| 53 | CHUK | 1.10000409 |
| 54 | MAP3K12 | 1.08706705 |
| 55 | MAP4K1 | 1.07362289 |
| 56 | NUAK1 | 1.06796113 |
| 57 | ERBB4 | 1.03641586 |
| 58 | BMPR1B | 1.03446286 |
| 59 | STK39 | 0.99576470 |
| 60 | MAP3K3 | 0.99220418 |
| 61 | OXSR1 | 0.98733091 |
| 62 | STK10 | 0.98103724 |
| 63 | IRAK1 | 0.90087816 |
| 64 | CAMK1D | 0.89585863 |
| 65 | MAP2K6 | 0.88974175 |
| 66 | MAPK15 | 0.88972208 |
| 67 | TIE1 | 0.88866742 |
| 68 | TRPM7 | 0.87639503 |
| 69 | NLK | 0.86021734 |
| 70 | TGFBR1 | 0.84609090 |
| 71 | FER | 0.82441776 |
| 72 | ITK | 0.80755097 |
| 73 | HCK | 0.79484776 |
| 74 | MAPK11 | 0.78014497 |
| 75 | ABL2 | 0.77586974 |
| 76 | ADRBK1 | 0.77259124 |
| 77 | CDK6 | 0.76724849 |
| 78 | ZAP70 | 0.76164017 |
| 79 | PRKCQ | 0.75785444 |
| 80 | GRK7 | 0.73428662 |
| 81 | MELK | 0.72697402 |
| 82 | CDC42BPA | 0.72517357 |
| 83 | PRKG2 | 0.72270378 |
| 84 | BTK | 0.70911091 |
| 85 | KDR | 0.70115622 |
| 86 | LCK | 0.70077310 |
| 87 | TTN | 0.70013591 |
| 88 | PRKAA2 | 0.67604246 |
| 89 | FLT3 | 0.66721555 |
| 90 | LYN | 0.66712461 |
| 91 | MST4 | 0.65574193 |
| 92 | PIM2 | 0.65181985 |
| 93 | TEC | 0.64346321 |
| 94 | MAP3K2 | 0.62963618 |
| 95 | GSK3A | 0.60728330 |
| 96 | MET | 0.58994103 |
| 97 | RPS6KA6 | 0.58593002 |
| 98 | EGFR | 0.57903385 |
| 99 | MAP2K3 | 0.57899918 |
| 100 | TRIB3 | 0.57737778 |
| 101 | SYK | 0.57632886 |
| 102 | BMPR2 | 0.57114222 |
| 103 | MAP2K2 | 0.56836196 |
| 104 | BMX | 0.56182147 |
| 105 | ABL1 | 0.55958228 |
| 106 | MOS | 0.55726599 |
| 107 | IGF1R | 0.54965595 |
| 108 | LIMK1 | 0.54856607 |
| 109 | WNK4 | 0.54624165 |
| 110 | PKN1 | 0.54454185 |
| 111 | MARK3 | 0.51761613 |
| 112 | MAP3K7 | 0.50886274 |
| 113 | MAPK7 | 0.49928442 |
| 114 | MAP2K1 | 0.49785122 |
| 115 | CAMK2D | 0.49282544 |
| 116 | EIF2AK2 | 0.48261310 |
| 117 | CAMK1G | 0.48177202 |
| 118 | ERBB3 | 0.46159003 |
| 119 | PDPK1 | 0.44764173 |
| 120 | STK4 | 0.44526944 |
| 121 | STK24 | 0.44237685 |
| 122 | NME2 | 0.43907622 |
| 123 | MAP3K1 | 0.42920611 |
| 124 | DYRK1B | 0.42645447 |
| 125 | MATK | 0.42005643 |
| 126 | PIM1 | 0.41442716 |
| 127 | LRRK2 | 0.41397191 |
| 128 | PDGFRB | 0.40830393 |
| 129 | MAPK4 | 0.40828135 |
| 130 | FGR | 0.40551828 |
| 131 | MAPK12 | 0.39907745 |
| 132 | PDK2 | 0.39627458 |
| 133 | ERBB2 | 0.38067301 |
| 134 | YES1 | 0.38039254 |
| 135 | RPS6KA2 | 0.37624138 |
| 136 | FGFR2 | 0.37255617 |
| 137 | PRKCD | 0.37191931 |
| 138 | PTK2 | 0.37173637 |
| 139 | GRK6 | 0.36372087 |
| 140 | PRKCE | 0.35567845 |
| 141 | DMPK | 0.34098956 |
| 142 | AKT3 | 0.32183198 |
| 143 | MAPKAPK2 | 0.31739898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.59340466 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.10492722 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80970781 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80498920 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68632883 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.52970487 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51487340 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42390027 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.20820382 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19592218 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11948516 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04984680 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.98683953 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79729960 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76502352 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75633475 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75171565 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74236097 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.72630273 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68840502 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60682578 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56053628 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.51190871 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.50070292 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47986228 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43000147 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39934276 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39131091 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37841337 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.33626905 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31134025 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28945660 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.28011664 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27949252 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26982555 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26917632 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23064414 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19815774 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15814557 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13691156 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13476204 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11137394 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07797900 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07414444 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 1.06788270 |
| 46 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02661317 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.01655727 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00909395 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.00208472 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99593320 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98784843 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97586163 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96754744 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.94626448 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94379430 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.93864822 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.93630250 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85620068 |
| 59 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85460356 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.85206465 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84794560 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84017092 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83733032 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83643025 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82975003 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.81119275 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.80608324 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80547961 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77633652 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77271792 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77110523 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76910865 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76746948 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75599549 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.75079173 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74968903 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73084191 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71595245 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69101514 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68683743 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64905482 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64896403 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64742034 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.64727218 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.62767848 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.62499441 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.61444489 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61363246 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61261024 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61157187 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57544592 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.57208744 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.56222445 |
| 94 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55676852 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52267288 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51790179 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51352804 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.50443274 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49593089 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.49211067 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48284920 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46586247 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46259351 |
| 104 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45864835 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45651515 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45372995 |
| 107 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44863955 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44145369 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43779004 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.43325531 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.42140601 |
| 112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41761250 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41556121 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.41027919 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39629893 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38822919 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.38582198 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37119185 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36006892 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35907521 |
| 121 | Apoptosis_Homo sapiens_hsa04210 | 0.35531117 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35256254 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34948900 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.34801421 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33234284 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.31782193 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30283977 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30174204 |

